Although LTB4-BLT1 signaling was shown to play a key role in anti-tumor responses, critically, the cell-specific roles of BLT1 in vivo are still unknown, and further studies that employ conditional cell-specific knockout of BLT1 are needed in these cancer models. The gene discussed is LTB4R; the disease is cancer.